HTR1A and Parkinson disease: We have hypothesized that 5-HT1A receptor agonist may have potential therapeutic effect in alleviating the motor symptoms of Parkinson’s disease and the augmentation of these agents to antiparkinson and neuroleptic drugs may increase the efficiency of antiparkinson and neuroleptic drugs (15).